Grifols SA - ESG Rating & Company Profile powered by AI
The assessment of Grifols SA uses intelligence from across the web as well as from public filings by Grifols SA. Alternative corporations in the rating industry group for Grifols SA are displayed below. Scroll down to the bottom of the page for potential risks for Grifols SA based on industry, location and marketcap.
Grifols SA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.7; made up of an environmental score of 7.0, social score of 8.0 and governance score of 8.0.
7.7
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 1 | Xlife Sciences AG | 8.0 | High |
| 1 | Zim Laboratories Ltd | 8.0 | High |
| 140 | Grifols SA | 7.7 | High |
| 140 | Novartis AG | 7.7 | High |
| 140 | Pfizer Inc | 7.7 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Grifols SA have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Grifols SA disclose current and historical energy intensity?
Sign up for free to unlockDoes Grifols SA report the average age of the workforce?
Sign up for free to unlockDoes Grifols SA reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Grifols SA disclose its ethnicity pay gap?
Sign up for free to unlockDoes Grifols SA disclose cybersecurity risks?
Sign up for free to unlockDoes Grifols SA offer flexible work?
Sign up for free to unlockDoes Grifols SA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Grifols SA disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Grifols SA conduct supply chain audits?
Sign up for free to unlockDoes Grifols SA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Grifols SA conduct 360 degree staff reviews?
Sign up for free to unlockDoes Grifols SA disclose the individual responsible for D&I?
Sign up for free to unlockDoes Grifols SA disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Grifols SA disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Grifols SA disclose water use targets?
Sign up for free to unlockDoes Grifols SA have careers partnerships with academic institutions?
Sign up for free to unlockDid Grifols SA have a product recall in the last two years?
Sign up for free to unlockDoes Grifols SA disclose incidents of discrimination?
Sign up for free to unlockDoes Grifols SA allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Grifols SA issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Grifols SA disclose parental leave metrics?
Sign up for free to unlockDoes Grifols SA disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Grifols SA disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Grifols SA disclose the pay ratio of women to men?
Sign up for free to unlockDoes Grifols SA support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Grifols SA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Grifols SA reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Grifols SA involved in embryonic stem cell research?
Sign up for free to unlockDoes Grifols SA disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Grifols SA disclose its waste policy?
Sign up for free to unlockDoes Grifols SA report according to TCFD requirements?
Sign up for free to unlockDoes Grifols SA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Grifols SA disclose energy use targets?
Sign up for free to unlockDoes Grifols SA disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Grifols SA have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Grifols SA
These potential risks are based on the size, segment and geographies of the company.
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuum"from prevention, screening, diagnosis, and prognosis to disease and treatment monitoring"to serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.